Patents by Inventor Keith Bupp

Keith Bupp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Targeting viral vectors to specific cells
    Patent number: 6762031
    Abstract: Methods for creating viral display libraries for purposes of isolating variants with modified target cell specificity and related methods; also retroviral display libraries.
    Type: Grant
    Filed: June 14, 2001
    Date of Patent: July 13, 2004
    Assignee: University of Medicine and Dentistry of New Jersey
    Inventors: Monica Judith Roth, Keith Bupp
  • Targeting viral vectors to specific cells
    Publication number: 20020164583
    Abstract: Methods for creating viral display libraries for purposes of isolating variants with modified target cell specificity and related methods; also retroviral display libraries.
    Type: Application
    Filed: June 14, 2001
    Publication date: November 7, 2002
    Inventors: Monica Judith Roth, Keith Bupp
  • Amyloid precursor-like protein and uses thereof
    Patent number: 5891991
    Abstract: The present invention is directed to isolated amyloid precursor-like proteins (APLPs), nucleotide sequences coding for and regulating expression of these protein, antibodies directed against these proteins, and recombinant vectors and host cells containing the genetic sequences coding for and regulating the expression of these protein sequences. The invention is also directed to isolated genomic. DNA, cDNA anti-sense RNA, and RNA containing the protein sequence. Antibodies can be used to detect an APLP in biological specimens, including, for example, fluid, serum or tissue samples. APLP1 and APLP2 are candidate genes for late onset familial Alzheimer's disease.
    Type: Grant
    Filed: August 6, 1996
    Date of Patent: April 6, 1999
    Assignees: The General Hospital Corporation, The Massachusetts Institute of Technology
    Inventors: Wilma Wasco, Keith Bupp, Margaret Magendantz, Rudolph Tanzi, Frank Solomon
  • Nucleic acid encoding amyloid precursor-like protein and uses thereof
    Patent number: 5851787
    Abstract: The present invention is directed to isolated amyloid precursor-like proteins (APLPs), nucleotide sequences coding for and regulating expression of these protein, antibodies directed against these proteins, and recombinant vectors and host cells containing the genetic sequences coding for and regulating the expression of these protein sequences. The invention is also directed to isolated genomic DNA, cDNA anti-sense RNA, and RNA containing the protein sequence. Antibodies can be used to detect an APLP in biological specimens, including, for example, fluid, serum or tissue samples. APLP1 and APLP2 are candidate genes for late onset familial Alzheimer's disease.
    Type: Grant
    Filed: January 21, 1993
    Date of Patent: December 22, 1998
    Assignees: The General Hospital Corporation, The Massachusetts Institute of Technology
    Inventors: Wilma Wasco, Keith Bupp, Margaret Magendantz, Rudolph Tanzi, Frank Solomon